Long-Term Survival of Patients with Metastatic Non-Small-Cell Lung Cancer over Five Decades

OBJECTIVE: Novel therapeutics and supportive care improved outcomes for metastatic non-small-cell lung cancer (mNSCLC) patients. Major advances over the past five decades include the introduction of combination chemotherapy, small molecules targeting mutant proteins, especially EGFR, and more recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar, Jair, Urban, Damien, Amit, Uri, Appel, Sarit, Onn, Amir, Margalit, Ofer, Beller, Tamar, Kuznetsov, Teodor, Lawrence, Yaacov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817269/
https://www.ncbi.nlm.nih.gov/pubmed/33519934
http://dx.doi.org/10.1155/2021/7836264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817269/
https://www.ncbi.nlm.nih.gov/pubmed/33519934
http://dx.doi.org/10.1155/2021/7836264

Ejemplares similares